Cargando…
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
BACKGROUNDS: Cancer cell resistance to chemotherapy drugs such as Gemcitabine, Oxaliplatin, Cisplatin, Doxorubicin, and 5-fluorouracil account for the main reason of chemotherapy failure for HCC patients, especially for those with advanced HCC or metastasis patients. This emerging resistance limits...
Autores principales: | Tang, Zuxiong, He, Jun, Zou, Jiayue, Yu, Shufei, Sun, Xiaoming, Qin, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051335/ https://www.ncbi.nlm.nih.gov/pubmed/33954040 http://dx.doi.org/10.7717/peerj.11200 |
Ejemplares similares
-
Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway
por: Wu, Shouhai, et al.
Publicado: (2016) -
Effects of ginkgol C17:1 on cisplatin-induced autophagy and apoptosis in HepG2 cells
por: Liu, Jun, et al.
Publicado: (2018) -
VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin
por: YAO, RUCHENG, et al.
Publicado: (2014) -
Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells
por: Rao, Qi, et al.
Publicado: (2022) -
HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway
por: Liang, Jiaqi, et al.
Publicado: (2023)